Anzeige
Erschienen in:
01.04.2017 | Cardiac Nuclear Imaging (A Cuocolo and M Petretta, Section Editors)
Radionuclide Imaging of Cardiac Device Infection
Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 4/2017
Einloggen, um Zugang zu erhaltenAbstract
Purpose of Review
Accurate diagnosis of cardiac device infection is critical for clinical decision-making and represents a challenge for current diagnostic methods. A non-invasive test with sufficient sensitivity and specificity to confirm or exclude infection would be desirable. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) has been emerging as a promising diagnostic tool for cardiac implantable electrophysiological devices (CIED) infection and its complications. The aim of this review is to describe the role of radionuclide imaging in cardiac device infection according to the different clinical presentations.
Recent Findings
18F-FDG PET/CT plays an important role in the diagnosis of CIED infection. It has been demonstrated that PET/CT imaging can accurately diagnose and distinguish deep pocket infection from superficial soft tissue infection. In lead infection, this technique has high specificity and is helpful when transthoracic echocardiography (TTE) does not detect vegetation. In addition, PET/CT may be useful in patients with suspected prosthesis valve endocarditis, in whom the initial TEE is negative or indeterminate.
Summary
The use of 18F-FDG PET/CT in the diagnosis of CIED infection has been implemented to respond to specific clinical needs. Different studies provided important data on the optimal conditions of PET/CT acquisition to better discriminate the infection. However, multicenter trials performed under standardized protocols for both acquisition and quantification of FDG uptake are needed. These efforts could help to achieve the level of evidence allowing FDG PET/CT to be included in clinical guidelines.